FDA OKs Trials for Nexalin's Sleep and Anxiety Therapy Headset
The FDA has agreed on the design for Nexalin's planned clinical studies of the Gen-3 HALO Clarity, targeting insomnia and anxiety.
Source: sleepreviewmag.com
📰 Studies Set News
Studies Set News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Studies Set. Real-time updates on events, politics, business and more.